Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion type Assertion NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_head.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion description "[In the pilot testing group, CST6 promoter was methylated in 8/27 (29.6%) operable breast cancer patients, in 6/46 (13.0%) patients with verified metastasis but none of 37 healthy individuals (0%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion evidence source_evidence_literature NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion SIO_000772 23006792 NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion wasDerivedFrom befree-20150227 NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.
- NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_assertion wasGeneratedBy ECO_0000203 NP333759.RAcCD4owMxOpxg79BBuOeAenCeIlk2IUVu9XNZaVvyANM130_provenance.